Blueshift Asset Management, LLC Kodiak Sciences Inc. Transaction History

Blueshift Asset Management, LLC

  • $267 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$5.04 - $9.48 $135,560 - $254,983
-26,897 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$7.09 - $89.45 $190,699 - $2.41 Million
26,897 New
26,897 $208,000
Q4 2020

Feb 12, 2021
SELL
$60.78 - $154.03 $263,602 - $668,028
-4,337 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$45.05 - $59.27 $195,381 - $257,053
4,337 New
4,337 $258,000

Others Institutions Holding KOD

# of Institutions
109
Shares Held
40.9M
Call Options Held
28.4K
Put Options Held
21.2K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $232M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email